NCT07182864 - MH004 Ointment in Healthy Adult Volunteers and Participants With Mild to Moderate Atopic Dermatitis | Biotech Hunter

Enrollment

160

Participants

Timeline

Start Date

January 6, 2022

Primary Completion Date

September 8, 2022

Study Completion Date

October 8, 2022

Conditions

Atopic Dermatitis (AD)

Interventions

DRUG

MH004 0.1% Ointment

MH004 0.1% ointment applied topically to the affected area as a thin film.

DRUG

MH004 0.3% Ointment

MH004 0.3% ointment applied topically to the affected area as a thin film.

DRUG

MH004 1.0% Ointment

MH004 1.0% ointment applied topically to the affected area as a thin film.

DRUG

MH004 3.0% Ointment

MH004 3.0% ointment applied topically to the affected area as a thin film.

DRUG

Vehicle Ointment

Matching vehicle ointment applied topically to the affected area as a thin film.

Trial Locations (1)

Huashan Hospital Affiliated to Fudan University, Shanghai